New epilepsy drug aims to quiet brain storms
NCT ID NCT06769659
First seen Oct 31, 2025 · Last updated Apr 25, 2026 · Updated 23 times
Summary
This study tests an experimental drug called NPT 2042 to see if it can reduce absence seizures in people with genetic generalized epilepsy. About 10 participants aged 16 to 75 will receive both the drug and a placebo in random order, with a two-week break in between. The main goal is to measure changes in seizure frequency using brain wave recordings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY, GENERALIZED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Trials, Inc. (CTI)
RECRUITINGLittle Rock, Arkansas, 77205, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.